Cornerstone Planning Group’s Avanos Medical AVNS Stock Holding History

Cornerstone Planning Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-170	Closed	-$4.25K	–	296
2026 Q2	$4.25K	Hold	170	–	–	﹤0.01%	1129
2026 Q1	$4.2K	Hold	170	–	–	﹤0.01%	1130
2025 Q4	$2.18K	Hold	170	–	–	﹤0.01%	1175
2025 Q3	$1.89K	Buy	170 +155	+1,033%	+$1.82K	﹤0.01%	1170
2025 Q2	$148	Hold	15	–	–	﹤0.01%	1474
2025 Q1	$186	Hold	15	–	–	﹤0.01%	1468
2024 Q4	$254	Sell	15 -57	-79%	-$1.13K	﹤0.01%	1309
2024 Q3	$1.63K	Hold	72	–	–	﹤0.01%	824
2024 Q2	$1.65K	Buy	72 +57	+380%	+$1.11K	﹤0.01%	822
2024 Q1	$296	Hold	15	–	–	﹤0.01%	993
2023 Q4	$336	Hold	15	–	–	﹤0.01%	817
2023 Q3	$303	Hold	15	–	–	﹤0.01%	972
2023 Q2	$383	Buy	+15	New	+$395	﹤0.01%	1480
2022 Q4	$432	Buy	+15	New	+$367	﹤0.01%	1470

Other funds holding AVNS

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Cornerstone Planning Group's AVNS Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 170 shares — an estimated $4.25K sold.

Cornerstone Planning Group first reported a position in AVNS in Q4 2022 and held it in 14 quarters. The position peaked at $4.25K in Q2 2026. 2 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

Cornerstone Planning Group reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
Cornerstone Planning Group sold 170 Avanos Medical shares in Q3 2026, an estimated $4.25K.
Cornerstone Planning Group first reported a position in Avanos Medical in Q4 2022 and held it in 14 quarters.
Cornerstone Planning Group's Avanos Medical position peaked at $4.25K in Q2 2026.
2 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.